Coronavirus update, 0900 GMT Friday the 13th

The Actuary’s Perspective: understanding risk

We humans are not very good at understanding risk; being struck by lightening, having a heart attack or getting cancer, or dying of the coronavirus, officially a “pandemic” as of this week.

We are told a group of people of a certain age, or preexisting condition, has an X% chance of dying from the coronavirus. But without being able to compare it to something we know as a background comparison, something in our pre-coronavirus real world, it is hard to understand.

Luckily, places like the CDC have stats galore. Table after table of the number of deaths per 100,000 of every age group. So let’s compare getting the coronavirus and recovering to just living, day after day, at certain points in life.

First thought experiment:

Which is safer, less likely to kill you? A: Being under 60 years old and getting the coronavirus, or B: Being any age, 15 years or older, and simply staying alive for 365 days, living from one birthday to the next.

If you picked A you are right! In Wuhan, about 28 people under age 60 out of every 100,000 died of the coronavirus. For comparison, according to the CDC, folks age 15-24 have a one year death rate of 80 per 100,000. So you are about three-times more likely to die just living for a year than you are of dying of the coronavirus. It goes up from there. So living one year, at any age after 15, is riskier than dying of the coronavirus! Skydivers excluded from this discussion! ?

Second thought experiment:

Let’s stack the deck against you.

In this experiment I will make you 75 years old, give you coronavirus and put you in the hospital. Are you on death’s door? No way. It’s still a pretty good risk. You have a 92% chance of leaving the hospital and returning to your life.

The other choice I will give you is being 75 years old and just living your life. We all know that if you are 75 years old, and even though you are active and having fun playing golf, taking long walks with friends, going to church, etc. you are at a higher risk of dying than you were when you were younger, say 30 years.

So how many years of just plain living at age 75, simply being alive, is the same as a hospital trip at age 75 with the coronavirus?

According to our friends at the CDC its about 19 months, about a year and a-half. I don’t want to scare you with this but as we all know, getting old is not for sissies; but the coronavirus doesn’t change your odds much one way or the other.

So everyone, have a good day! We’ll get through this!

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies

Dr. Steven Quay investigates COVID-19's origins, analyzing evidence that suggests SARS-CoV-2 may have resulted from a lab incident rather than natural transmission. Through statistical methods, Dr. Quay estimates a 98% probability of a lab origin, challenging popular theories about animal-to-human transmission and highlighting possible lab safety issues in Wuhan. In this video, he also emphasizes the importance of global safety regulations to prevent future pandemics. Watch to uncover key insights on COVID-19's origins and why lab safety matters for global health.

This video describes the clinical data from the Atossa Therapeutics press release of October 31, 2024 entitled, Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer